Page last updated: 2024-10-29

ioxilan and Coronary Disease

ioxilan has been researched along with Coronary Disease in 1 studies

Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jabara, R1
Gadesam, RR1
Pendyala, LK1
Knopf, WD1
Chronos, N1
Chen, JP1
Viel, K1
King, SB1
Manoukian, SV1

Other Studies

1 other study available for ioxilan and Coronary Disease

ArticleYear
Impact of the definition utilized on the rate of contrast-induced nephropathy in percutaneous coronary intervention.
    The American journal of cardiology, 2009, Jun-15, Volume: 103, Issue:12

    Topics: Angioplasty, Balloon, Coronary; Contrast Media; Coronary Angiography; Coronary Disease; Female; Foll

2009